Company intelligence / Profile preview
Medika Natura
Not explicitly stated., Penang / Perak / Selangor / Negeri Sembilan*, Malaysiamedikanatura.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Phase 2
01
Overview
Medika Natura’s lead product, SFK7®/LABEESITY®, a standardized extract from Labisia pumila, has completed Phase 2 RCTs in Malaysia and Indonesia targeting obesity with positive outcomes. The product is now undergoing Phase 3 studies in Malaysia alongside an IND submission to the US FDA. Pre-clinical data also support potential benefits in diabetes and cancer. LABEESITY® has received regulatory approvals as a dietary supplement or traditional medicine in Malaysia, Indonesia, Singapore, the US FDA (as NDI), and is seeking further international clearances.[3][4][5]
- Therapeutic areas
- Metabolic DisordersEndocrinologyOncologyInfectious Diseases
- Modalities
- Botanical extractsStandardized herbal compounds[2][3]
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
03
Partnerships
Malaysian Ministry of Agriculture & Food Industry (“anchor company” status)[3]Collaborations with Universiti Sains Malaysia,[3] Universiti Putra Malaysia,[4] Universiti Kebangsaan Malaysia,[4] Institute for Medical Research [IMR], Ministry of Health facilities in multiple Malaysian states,[4] public health facilities in Indonesia,[4] private hospital partner in Hyderabad India.[4]
Beyond the preview
Go deeper on Medika Natura.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medika Natura.